Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vallance

Showing results (181-190 of 1,388) with videos related to

Pageof 139
Sort By:
Clinical Pharmacology and Therapeutics|April 22, 2010
The future is much closer collaboration between the pharmaceutical industry and academic medical centersP Vallance, P Williams, C Dollery
British Journal of Clinical Pharmacology|September 1, 1982
Atenolol reduces blood pressure and FEV in normal subjectsR W Fuller, P J Vallance
Cardiovascular Research|November 1, 1994
Forearm blood flow responses to a nitric oxide synthase inhibitor in patients with treated essential hypertensionA Calver, J Collier, P Vallance
BMJ (Clinical Research Ed.)|November 21, 1992
Domiciliary thrombolysis by general practitionersP H Seidelin, B D Vallance
The European Journal of Medicine|January 1, 1993
Nitric oxide and the control of human vascular tone in health and diseaseA Calver, J Collier, P Vallance
Eye (London, England)|July 24, 2004
Neurofibromatosis type 1 presenting with Horner's syndromeP Cackett, J Vallance, H Bennett
European Journal of Clinical Pharmacology|January 1, 1992
The effect of endothelium-derived nitric oxide on ex vivo whole blood platelet aggregation in manP Vallance, N Benjamin, J Collier
Vascular Medicine (London, England)|February 1, 2006
Endogenous production of nitric oxide synthase inhibitorsShelagh Anthony, James Leiper, Patrick Vallance
Lancet (London, England)|May 10, 1997
Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link?P Vallance, J Collier, K Bhagat
Lancet (London, England)|December 21, 1991
Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shockA Petros, D Bennett, P Vallance
Pageof 139

Showing results (181-190 of 1,388) with videos related to

Sort By:
Pageof 139
Clinical Pharmacology and Therapeutics|April 22, 2010
The future is much closer collaboration between the pharmaceutical industry and academic medical centersP Vallance, P Williams, C Dollery
British Journal of Clinical Pharmacology|September 1, 1982
Atenolol reduces blood pressure and FEV in normal subjectsR W Fuller, P J Vallance
Cardiovascular Research|November 1, 1994
Forearm blood flow responses to a nitric oxide synthase inhibitor in patients with treated essential hypertensionA Calver, J Collier, P Vallance
BMJ (Clinical Research Ed.)|November 21, 1992
Domiciliary thrombolysis by general practitionersP H Seidelin, B D Vallance
The European Journal of Medicine|January 1, 1993
Nitric oxide and the control of human vascular tone in health and diseaseA Calver, J Collier, P Vallance
Eye (London, England)|July 24, 2004
Neurofibromatosis type 1 presenting with Horner's syndromeP Cackett, J Vallance, H Bennett
European Journal of Clinical Pharmacology|January 1, 1992
The effect of endothelium-derived nitric oxide on ex vivo whole blood platelet aggregation in manP Vallance, N Benjamin, J Collier
Vascular Medicine (London, England)|February 1, 2006
Endogenous production of nitric oxide synthase inhibitorsShelagh Anthony, James Leiper, Patrick Vallance
Lancet (London, England)|May 10, 1997
Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link?P Vallance, J Collier, K Bhagat
Lancet (London, England)|December 21, 1991
Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shockA Petros, D Bennett, P Vallance
Pageof 139